NCT01896336View on ClinicalTrials.gov

Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 18, 2013

Primary Completion Date

November 11, 2013

Study Completion Date

December 10, 2013

Conditions
Primary Insomnia
Interventions
DRUG

Zolpidem Hemitartrate

"Patz - 5mg sublingual zolpidem hemitartrate~1 QD~Stilnox - 10mg oral zolpidem hemitartrate~1 QD"

Trial Locations (1)

04020-060

AFIP, São Paulo

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
collaborator

Associação Fundo de Incentivo à Pesquisa

OTHER

lead

EMS

INDUSTRY

NCT01896336 - Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia | Biotech Hunter | Biotech Hunter